Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Multicenter Study of 5-Aminolevulinic Acid 5-ALA to Enhance Visualization of Malignant Tumor in Patients with Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE
Study Type: Prevention
Phase: N/A
NCTID: NCT04905069
Principal Investigator:
Ronald Chen
The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers
Study Type: Prevention
Phase: N/A
NCTID: NCT05555069
Principal Investigator:
Nicole Nollen
BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase III Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women carrying a BRCA1 Germline Mutation
Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation
Study Type: Prevention
Phase: III
NCTID: NCT05711667
Principal Investigator:
Ibrahim Ahmed
Phase 2 Study of Low Dose Tamoxifen +/- High Dose Omega-3 Fatty Acids in Overweight Postmenopausal Women at Increased Risk for Breast Cancer
Study Type: Prevention
Phase: II
NCTID: NCT06195306
Principal Investigator:
Lauren Nye
The Effectiveness of Lactobacillus Plantarum LBP in Preventing Acute Graft-Versus-Host Disease GvHD in Children Undergoing Alternative Hematopoietic Progenitor Cell Transplantation HCT
Study Type: Prevention
Phase: III
NCTID: NCT03057054
Principal Investigator:
Keith August
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine DFMO
Study Type: Prevention
Phase: II
NCTID: NCT02679144
Principal Investigator:
Kevin Ginn